| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Robert L Erwin last filed a Form 4 in June 2020, as President at IBIO. Robert L Erwin's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 108,108 shares of IBIO. The IBIO filings lean toward selling, a net 124,392 shares.
Robert L Erwin has 4 Form 4 filings on record from May 2017 to June 2020, all as President at iBio (IBIO), 2017–2020.
The 21 reported transactions were 9 option or other derivative awards, 8 dispositions back to the company, 2 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $204K.
The largest open-market sale was 96,124 shares of IBIO at an average $1.62 on June 2, 2020, about $156K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.